ThesisBlockade of EIF5A hypusination/activation reverses TGFbeta-induced EMT and potently kills metastatic breast cancer cells in combination with HDAC6 inhibitionAdamian, YvessMetastatic breast cancers carry a 5-year survival prognosis of less than 20%. Thus, it is highly desirable to identify therapeutic strategies that specifically target both primary and metastatic tumors. It is generally accepted that epithelial-mesench . . .